Literature DB >> 8460723

The ethics of blinded HIV surveillance testing.

R Bayer1.   

Abstract

Keywords:  Centers for Disease Control; Health Care and Public Health; Office for Protection from Research Risks

Mesh：

Year:  1993        PMID： 8460723      PMCID： PMC1694475          DOI： 10.2105/ajph.83.4.496

Source DB:  PubMed          Journal:  Am J Public Health        ISSN： 0090-0036            Impact factor:   9.308


× No keyword cloud information.
  3 in total

Review 1.  The American, British and Dutch responses to unlinked anonymous HIV seroprevalence studies: an international comparison.

Authors:  R Bayer; L H Lumey; L Wan
Journal:  AIDS       Date:  1990-04       Impact factor: 4.177

2.  HIV antibody screening. An ethical framework for evaluating proposed programs.

Authors:  R Bayer; C Levine; S M Wolf
Journal:  JAMA       Date:  1986-10-03       Impact factor: 56.272

3.  HIV surveillance testing: taking advantage of the disadvantaged.

Authors:  S H Isaacman
Journal:  Am J Public Health       Date:  1993-04       Impact factor: 9.308
  3 in total
  4 in total

1.  Defending HIV seroprevalence surveys.

Authors:  J W Buehler; L R Petersen; J W Ward; R O Valdiserri
Journal:  Am J Public Health       Date:  1994-02       Impact factor: 9.308

2.  Conducting unlinked anonymous HIV surveillance in developing countries: ethical, epidemiological, and public health concerns.

Authors:  Stuart Rennie; Abigail Norris Turner; Bavon Mupenda; Frieda Behets
Journal:  PLoS Med       Date:  2009-01-20       Impact factor: 11.069

3.  The ethics of unlinked anonymous testing of blood: views from in-depth interviews with key informants in four countries.

Authors:  Anthony S Kessel; Jessica Datta; Kaye Wellings; Sarah Perman
Journal:  BMJ Open       Date:  2012-12-20       Impact factor: 2.692

4.  HIV recency testing: should results be disclosed to individuals tested?

Authors:  Quarraisha Abdool Karim; Ruth Macklin; Sofia Gruskin; Sara Klucking; Lejeune Lockett; Celia J Maxwell; Kenneth H Mayer; Edwin Sanders; Frederick Sawe
Journal:  J Int AIDS Soc       Date:  2020-08       Impact factor: 5.396
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.